Nevanac
Product Images NDC 0078-0778

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nevanac (NDC 0078-0778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Of Nepafenac (Nevanac 01)

Chemical structure diagram of the active ingredient for NEVANAC by Novartis Pharmaceuticals Corporation, depicting molecular bonds and functional groups typical of a non-steroidal anti-inflammatory drug.*

FDA Label Image

Principal Display Panel Ndc 0078-0778-03 Sterile Nevanac® (nepafenac Ophthalmic Suspension) 0.1% 3 mL Novartis (Nevanac 02)

The packaging label for Nevanac (nepafenac ophthalmic suspension) 0.1% shows a 3 mL bottle. It includes labeling for sterile topical ophthalmic use, instructions for dosage, and storage conditions. The manufacturer is Alcon Laboratories, Inc., with distribution by Novartis Pharmaceuticals Corporation. The label features the Novartis logo and lists active and inactive ingredients along with barcodes and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.